BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33475968)

  • 21. [Mesalazine-induced acute pericarditis].
    Sierra Ausín M; Rascarachi G; Díez Rodríguez R; Arias Rodríguez L; Del Pozo Maroto E; Muñoz Núñez F
    Gastroenterol Hepatol; 2010 Apr; 33(4):338-9. PubMed ID: 20005014
    [No Abstract]   [Full Text] [Related]  

  • 22. [Interstitial pneumonia related to mesalamine].
    Lamsiah T; Moudden K; Baaj M; Hadri L
    Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesalazine-induced myocarditis: a case report.
    Radhakrishnan ST; Mohanaruban A; Hoque S
    J Med Case Rep; 2018 Feb; 12(1):44. PubMed ID: 29467009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesalamine lung toxicity.
    Jain N; Petruff C; Bandyopadhyay T
    Conn Med; 2010 May; 74(5):265-7. PubMed ID: 20509416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of ulcerative colitis associated with interstitial pneumonitis during administration of 5-aminosalicylic acid].
    Ogino H; Tachibana Y; Yonejima H; Satomura Y; Unoura M; Miwa A
    Nihon Shokakibyo Gakkai Zasshi; 1999 Feb; 96(2):164-9. PubMed ID: 10087889
    [No Abstract]   [Full Text] [Related]  

  • 26. Mesalamine-induced myopericarditis in a paediatric patient with Crohn's disease.
    Nair AG; Cross RR
    Cardiol Young; 2015 Apr; 25(4):783-6. PubMed ID: 24915235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD; Woseth DM; Thisted RA; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of distal ulcerative colitis: now the patients have the choice.
    Schölmerich J
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):685-7. PubMed ID: 10730560
    [No Abstract]   [Full Text] [Related]  

  • 29. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comment: Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis and the Kounis syndrome.
    Kounis GN; Kouni SA; Chiladakis JA; Kounis NG
    Ann Pharmacother; 2009 Feb; 43(2):393-4. PubMed ID: 19141654
    [No Abstract]   [Full Text] [Related]  

  • 34. Febrile pleuropericarditis, a potentially life-threatening adverse event of balsalazide--case report and literature review of the side effects of 5-aminosalicylates.
    Coman RM; Glover SC; Gjymishka A
    Expert Rev Clin Immunol; 2014 May; 10(5):667-75. PubMed ID: 24689504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily, high-concentration MMX mesalamine in active ulcerative colitis.
    Kamm MA; Sandborn WJ; Gassull M; Schreiber S; Jackowski L; Butler T; Lyne A; Stephenson D; Palmen M; Joseph RE
    Gastroenterology; 2007 Jan; 132(1):66-75; quiz 432-3. PubMed ID: 17241860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesalamine-induced myocarditis following diagnosis of Crohn's disease: a case report.
    Galvão Braga C; Martins J; Arantes C; Ramos V; Vieira C; Salgado A; Magalhães S; Correia A
    Rev Port Cardiol; 2013 Sep; 32(9):717-20. PubMed ID: 23993290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once-daily mesalamine (Lialda) for ulcerative colitis.
    Med Lett Drugs Ther; 2007 Mar; 49(1257):25-6. PubMed ID: 17375030
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-induced bradycardia.
    Gn D; Patil M; Shafiq S
    Clin Med (Lond); 2023 Mar; 23(2):173-174. PubMed ID: 36958845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
    Murphy SJ; Mayer L; Abreu MT
    J Clin Gastroenterol; 2011 Jan; 45(1):83-4. PubMed ID: 20535023
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
    Lichtenstein GR; Kamm MA; Boddu P; Gubergrits N; Lyne A; Butler T; Lees K; Joseph RE; Sandborn WJ
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):95-102. PubMed ID: 17234558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.